康希诺生物：截至2025年12月31日止的年度业绩公告

CanSino Biologics Inc. 6185 20251231 20251231 20251231 (www.hkexnews.hk)(www.cansinotech.com)20251231 Xuefeng YU 2026330 Xuefeng YUShou Bai CHAO 279 480 782 2783 34167 53 74 Xuefeng YU Xuefeng YUShou Bai CHAO (FCG HKFCG (PE)) 185401–420 33191901 H 183171712–1716 Xuefeng YU 1526 Xuefeng YU 77334 •8835 6185688185 www.cansinotech.com 20252025 20251,059.428.4%27.9 2022®®2025967.721.9%®3~683®7–59 ––13CRM197/TT®®®20 6 1,900II I 2026124 ®13PIC/S GMPGMPPIC/S (PQ) 2025ESG2025ESG2025 3(i)®®®Ad5–EBOVPBPVDTcP–Hib–MCV4PCV24(ii)®®®DTcPTdcp(iii)CS–2606 mRNACS–2023 • ®® ®NDAMCV4® ®IIIMCV2®3623 20211220216®®NDA20262®®MCV4®MPSV4®3683 ® ®967.721.9% 202412MCV4MCV41855MCV4 20252MCV4(LPPOM MUI)MCV4 20262MCV433473683 ®759 ® ®T2B 20256®NDA®NDA ®®® ®20 ®®®XBB.1.5 ®5SCOVID–19 ®®®®®®®®® 20212®NDANDA 20229®® 202312XBB.1.5XBB.1.5 Ad5–EBOV Ad5–EBOV50% 201710Ad5–EBOVNDAAd5–EBOVGMP Ad5–EBOV(i)2º C8º C12(ii)(iii) Ad5–EBOVAd5–EBOV • DTcP DTcP(DTaP)DTcP DTcPDTcPTdcpDTcP 202412DTcPNDA 20252DTcPNDANDAsDTcPNDADTcP2026NDA 20252NDA2026NDA 20253 Tdcp Tdcp6 TdcpBoostrixAdacel 202412TdcpII/IIITdcpIIINDA • 20241I 202412I/IIIII/II 20257 PBPV PBPV23(PPV23)13(PCV13)2390PBPVAPspAPBPVPPV23PCV13 20244PBPVIIaIbIaIbPBPVIPBPV 20237Barinthus Biotherapeutics (UK) LimitedVaccitech (UK) LimitedShingrixShingrix 202311II I Ad5Ag85AIaI Ib 20255II1849 202511I DTcP–Hib–MCV4 DTcP–Hib–MCV4MCV4®DTcPIIIHibIDTcP–Hib–MCV4 20252DTcP–Hib–MCV4 202512DTcP–Hib–MCV4I PCV24 PCV2426242424 202612026PCV24I • mRNA mRNACMC(Chemistry, Manufacturing and Controls)mRNAmRNA 20247(NIBM)mRNAmRNA 20256(ISL)ISL–3C–LNPISLISL–3C–LNP 202511ISL–3C–LNPmRNAISL–3C–LNPLNPmRNAPRBT001mRNA ®®®mRNAmRNA A ®MCV4MCV®®®®® (COC)®®® 202512311,059.42024824.9®16.8 20251231260.120241231244.415.76.4%(i)(ii) 20251231799.320241231580.5218.8 20241231109.552.0%20251231166.4 20251231416.712.9%28.4% 20241231194.410.9%20251231173.1 20241231416.124.8%20251231313.0 2024123181.9202512314.6(1)70.5(2)4.50.5(3)6.3 – 2025123122.52024123122.244.7(1)18.517.4(2)29.1(3)21.4 202512316.120242.5 20241231180.120251231224.5III 20241231280.520251231338.320241231439.720251231361.5 20241231737.620251231782.9 20241231113.72025123190.919.411.2 2024123162.52025123150.4202512 31 20241231632.35.2%20251231599.4(i)(ii) 2024123175.12025123153.0 202412311,556.521.6%202512311,219.7 202512313,838.8202412314,282.51,219.7988.41,630.7 202512311,082.5202412311,772.0318.5599.4164.6 20251231318.520241231892.2956.9202412311,098.5MCV4 20251231988.0 202512312,244.7898.7 202433ª Vara Civel de Maringa/PRBelcher Farmaceutica Ltda.Belcher2021COVID–19167213 BelcherBelcher20251231 20251231 2025123118.820241231129.285.5% 2025123120251231149.020241231158.9 20251231 20251231 (i)(ii)2025123115.0104.812 3100%202512311.12%202412318.14% Xuefeng YU19636Yu20092009YuYu198571988619986(McGill)Yu30Yu1998–Sanofi Pasteur Limited–Yu19961998IBEX Technologies Inc.20244IBTYuAerasAeras Global TBVaccine FoundationAd5–EBOVAd5–nCoVYu10YuYu202072552 Shou Bai CHAO196282018ChaoChao1982719857199210Chao30ChaoGMP2011(ISPE)ChaoChaoCOVID–19ChaoChaoCOVID–19COVID–19 王 靖19801220212021202020212017202120201274320192020A+H 李 志 成19575202420241202412CSL Behring Asia Pacific Limited20222024201520222012201520062011Cephalon Inc.199720058Merck1996Abbott Laboratories Taiwan Limited19801995 202511Aulis Capital20251Stratation ConsultantsLimited20246Cognitact Limited2022TE Healthcare Advisory PteLtd20202022212620152023CSL BehringAsia Pacific Limited20132015 2012201519801119869200610 張 耀 樑195910202423019861020151202012 2023255220241548202552021ADAG 20202024212620182020201320182011201320102011200920102006 1982619838 左 敏1961520251130 20241099662025700279320257 201362023626076016072017820238202082023820219202482020920249 紀 雪 峰1978520251110 2024112024620246126520231020233 20191201912•20162018(PPP) 2001620046 朱 濤19732200912024220091199571998620034(University ofPittsburgh)200410(Carnegie Mellon University)20042005Integrated Genomics Inc.20062008Ad5–EBOVCOVID–19COVID–19 Dongxu QIU19601Qiu2009120242Qiu2009120211QiuQiu1982719871219891119914(University of Konstanz)1992519931(University of Montreal)Qiu200010(University of Western Ontario)QiuQiu19931998Biomira, Inc.19992000Altarex Inc.20002002ARIUS Research Inc.20032005MDS Capital2006200920072011ChinaBioLLCQiuPCV13PPV23AHQiuIII 崔 進19873202192018201920162017201820182021201520162012201520096201112 崔 進1987320193 趙 明 璟1977220193VistraCorporate Services (HK) Limited202003201592020202519996200311 20251127 C1 C.2.135 C3 Xuefeng YUShou Bai CHAO 2025112720251127 2733 202511272025(i)(ii)(iii)(i)(ii)(i)(ii)(i)(ii)(iii) C.2.1HYuYu (i)(ii)Yu(iii) C.2.1 Xuefeng YUShou Bai CHAO 202511193.09D 3.21C1 (1)202511272025102720251127 (2)202511 27202511 27 • •2025•••••• 3.25C1 (1)202511272025102720251127(2)20251127(i)(ii)20251127 ••••2025H2025A 42 20251231 1,500,0001,500,001- 2,000,0002,000,001- 2,500,0002,500,00